Global Poultry Vaccines
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Poultry Vaccines market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Poultry Vaccines market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Segment Analysis | Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Others |
| Application Segment Analysis | Broiler, Layer, Breeder |
| Disease Type Segment Analysis | Infectious Bronchitis, Infectious Bursal Diseases, Marek's Disease, Newcastle Disease, Other Diseases |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Poultry Vaccines Market Report 2025.
The global Poultry Vaccines market was valued at USD 1.95 Billion in 2022 and will reach USD 3.82 Billion by 2030, registering a CAGR of 10.8% for the forecast period 2023-2030.
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Poultry Vaccines Market Sales Revenue | xxxx | xxxx | xxxx | 10.8% |
Poultry Vaccines Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
What is the poultry vaccine market?
Poultry vaccines are used to prevent various diseases by significantly accelerating the immune system to produce antibodies to fight against invading organisms. The control and prevention of chicken diseases is significantly aided by poultry vaccinations. The bulk of vaccines made from chicken are designed to combat viral infections. These vaccinations are given in a variety of ways, including nasal, ocular, oral, intramuscular, in vivo, and subcutaneous. The growth of the poultry vaccines market is attributed to the increasing demand for poultry health along with rising poultry headcount and rising prevalence of zoonotic diseases. Additionally, the rising demand for poultry-related food products, government initiatives, rising meat consumption worldwide, cutting-edge manufacturing technologies for new vaccines, and rising poultry healthcare costs are all factors contributing to the growth of the market.
Rising R&D expenses by key players:
The expanding R&D efforts to introduce poultry vaccines to cure illnesses and their expanding product approvals by key market players over the anticipated drive the market. For example, the Salmonella polyvalent inactivated vaccine is offered by Venkys India and is used to prevent and treat salmonellosis in breeders, layers, and broilers. The KM Biologics portfolio also includes OILVAX EDS-76, a highly successful treatment for egg drop syndrome. The market for poultry vaccines is expanding due to such initiatives taken by major players in the market.
Technological advancement in the vaccine industry:
A number of businesses involved in the poultry vaccination industry are concentrating on introducing innovative technology solutions to strengthen their positions. For instance, in 2020, the VAXXITEK HVT+IBD+ND vaccine was introduced by the German pharmaceutical company Boehringer Ingelheim to safeguard poultry against three different illnesses. The immune system is strengthened with VAXXITEK HVT+IBD+ND, which also provides enhanced defenses against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). This contributes to the expansion of the market for poultry vaccines.
Restraining Factor:
Side-effects of poultry vaccinations:
The use of poultry vaccines has a number of side effects. Head swelling, a slight discharge from the eye or nose, swelling at the injection site, localized pain, decreased appetite and activity, a mild fever, sneezing, and a moderate cough are examples of local effects. These obstacles are hindering the market growth for poultry vaccines.
Impact of the COVID-19 pandemic on the Poultry Vaccines Market:
The COVID-19 outbreak had a negative effect on the poultry market by lowering demand, resulting in poor sales, unsold stocks, and driving down the cost of chicken meat and eggs. In nations like India where there are big numbers of chickens, the effect was more noticeable. Although the production of eggs, milk, and meat was among the critical services, the supply chain was hampered by the lockdown and mobility restrictions. The pandemic's negative effects were worsened by these obstacles as well as the appearance and widespread concern of other avian diseases, such as bird flu in India.
However, the COVID-19 pandemic has given vaccine producers opportunities to take advantage to increase their market share. This is due to people are becoming more aware of animal illnesses, there is a desire for safe food and products, and zoonoses are a worry.
We have various report editions of Poultry Vaccines Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.
October 2022
Zoetis expanded its poultry vaccine portfolio:
Zoetis expanded its poultry vaccine portfolio by introducing the recombinant vector vaccine Poulvac Procerta HVT-IBD-ND, which provides early/robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.
April 2022
Elanco launched a new animal healthcare company BiomEdit:
Elanco and Ginkgo Bioworks, in collaboration launched a new animal healthcare business called BiomEdit to create medications, dietary supplements, and disease-monitoring techniques for cattle. The new company, BiomEdit wants to address antibiotic resistance and increase sustainability.
January 2020
Boehringer Ingelheim announced the launch of a new vaccine:
Boehringer Ingelheim introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against a number of illnesses, including Marek's disease, Newcastle disease, and infectious bursal disease (classic and variant kinds).
Top Companies Market Share in Poultry Vaccines Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Boehringer Ingelheim International GmbH | xxxx | xxxx | xxxx | xxxx |
| Phibro Animal Health Corporation | xxxx | xxxx | xxxx | xxxx |
| Ceva | xxxx | xxxx | xxxx | xxxx |
| Biovac | xxxx | xxxx | xxxx | xxxx |
| Zoetis | xxxx | xxxx | xxxx | xxxx |
| Merck & Co. Inc. | xxxx | xxxx | xxxx | xxxx |
| Elanco | xxxx | xxxx | xxxx | xxxx |
| Venkys India | xxxx | xxxx | xxxx | xxxx |
| Vaxxinova International BV | xxxx | xxxx | xxxx | xxxx |
| Hester Biosciences Limited | xxxx | xxxx | xxxx | xxxx |
| KM Biologics | xxxx | xxxx | xxxx | xxxx |
| Calier | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America is predicted to have a sizable share of the global market for poultry vaccine over the forecast period owing to factors including rising consumer awareness of food safety, rising consumption of products derived from poultry, and rising incidence of zoonotic diseases connected to poultry. The US Department of Agriculture (USDA) reports that the per capita consumption of chicken products raised from 107.6 pounds in 2016 to 108.6 pounds in 2017. In addition, according to figures provided by the UNFAO, the North America region is producing more eggs and hens. Additionally, in North America, nucleic acid-mediated vaccinations, live vector vaccines, non-replicating recombinant antigen vaccines, and live-gene-deleted vaccines have all been developed.
The current report Scope analyzes Poultry Vaccines Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Poultry Vaccines Market is witnessing significant growth in the near future.
In 2023, the Attenuated Live Vaccines segment accounted for noticeable share of global Poultry Vaccines Market and is projected to experience significant growth in the near future.
The Broiler segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Boehringer Ingelheim International GmbH , Ceva and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Research Analyst
LinkedIn | Profile | Book Appointment
Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.
Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Poultry Vaccines Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Poultry Vaccines Industry growth. Poultry Vaccines market has been segmented with the help of its Product, Application Disease Type, and others. Poultry Vaccines market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Based on product, the market is segmented into attenuated live vaccines, inactivated vaccines, recombinant vaccines, and others. The attenuated live vaccines segment is the dominating segment of the market. In comparison to other types of immunizations, these vaccines can cause the immune system to manufacture more antibodies. Additionally, immunization has a longer shelf life and offers defense against avian illnesses such as infectious bronchitis, infectious bursitis, and Newcastle disease. Additionally, the market is developing as a result of expanding R&D efforts, notably in the area of vaccination, to stop various outbreaks of the illnesses indicated above.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Poultry Vaccines Industry. Request a Free Sample PDF!
By application, the market is classified into broiler, layer, and breeder. The breeder segment has the highest revenue share of the market. Owing to the rising number of breeder farms that are generating viable eggs, which are hatched in a hatchery, the breeder segment is anticipated to increase at the quickest rate during the projected period. The market has expanded because of the increasing productivity of breeding farms. The government's different vaccination programs for breeders can also be credited with the market expansion since they safeguard both the vaccinated birds and their offspring, e.g. broilers.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
By disease type, the market is segmented into infectious bronchitis, infectious bursal diseases, Marek's disease, Newcastle disease, and other diseases. The bronchitis segment is anticipated to lead the poultry vaccine market during the course of the projected year. The dominance of the segment is because of the rising prevalence of bronchitis. A frequent and contagious illness that affects poultry animals is infectious bronchitis. It has a significant morbidity rate and is a fairly widespread illness.
Disclaimer:
| Product | Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Others |
| Application | Broiler, Layer, Breeder |
| Disease Type | Infectious Bronchitis, Infectious Bursal Diseases, Marek's Disease, Newcastle Disease, Other Diseases |
| List of Competitors | Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Ceva, Biovac, Zoetis, Merck & Co. Inc., Elanco, Venkys India, Vaxxinova International BV, Hester Biosciences Limited, KM Biologics, Calier |
Chapter 1 2026 Geopolitical Outlook - Poultry Vaccines Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review Global Poultry Vaccines Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review North America Poultry Vaccines Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review Europe Poultry Vaccines Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review Asia Pacific Poultry Vaccines Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review South America Poultry Vaccines Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review Middle East Poultry Vaccines Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Poultry Vaccines. Further deep in this chapter, you will be able to review Middle East Poultry Vaccines Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Poultry Vaccines. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Disease Type Analysis 2022 - 2034
Chapter 15 Poultry Vaccines Price Trend Analysis
Chapter 16 Poultry Vaccines Import/Export Analysis
Chapter 17 Poultry Vaccines Production Analysis
Chapter 18 Gap Analysis
Chapter 19 Strategy Analysis
Chapter 20 Profitability and Gross Margin Analysis
Chapter 21 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Poultry Vaccines market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.
Cal-Maine Foods facility in Parmer County, Texas, has temporarily halted operations due to highly pathogenic avian influenza detected on the premises. The company depopulated around 1.6 million laying hens and 337,000 pullets, or 3.6% of its total flock, as of March 2. Texas Agriculture Commissioner Sid Miller emphasized the need for producers to practice heightened biosecurity measures due to the rapid spread of the virus. The detection comes as a peculiar strain of avian influenza affects dairy cow herds in Texas, Kansas, Michigan, and other parts of the country. There is now little risk to the public, and national and state organizations are updating their guidelines as new information becomes available. Bird flu has already caused Cal-Maine to suspend production; a comparable outbreak occurred in Kansas during the third quarter that ended on March 2. Due to a "significant decrease" in egg prices, the company reported net sales of $703 million in the third quarter, which was 30% less than the same period last year. The most recent quarter's net income was $146.7 million, while sales volumes rose by 3% over the previous one.